SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Generic and therapeutic substitutions in the UK: are they a good thing?
2 references·7 citing·27 second hop
Generic and therapeutic substitutions in the UK: are they a good thing? (2010)Generic and therapeutic substitutions in …Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)Clinical Equivalence of Gener…What do primary care patients think about generic drugs? (2005)What do primary care patients…The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians (2015)The prescribing of generic me…Potential Clinical and Economic Impact of Switching Branded Medications to Generics (2015)Potential Clinical and Econom…Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review (2015)Disinvestment and Value-Based…Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark (2014)Regulation of pharmaceutical …Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries (2013)Reforms and initiatives in Sc…Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications (2011)Policies to Enhance Prescribi…European Society for Organ Transplantation Advisory Committee Recommendations on Generic Substitution of Immunosuppressive Drugs (2011)European Society for Organ Tr…Statistical Methods for Meta-Analysis (1988)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Evaluating non-randomised intervention studies (2003)A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study (2013)Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending (2017)The Theory of Industrial Organization (1988)Estimating long-run relationships from dynamic heterogeneous panels (1995)The Log of Gravity (2006)Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance (2009)Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications (2010)Cochrane Database of Systematic Reviews (2011)European Healthcare Policies for Controlling Drug Expenditure (2003)Patients’ attitudes towards and experiences of generic drug substitution in Norway (2006)Patients’ Perceptions Of Generic Medications (2009)Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications (2012)Demand-side policies to encourage the use of generic medicines: an overview (2013)Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries (2020)Encouraging the use of generic medicines: implications for transition economies. (2002)Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration (2009)The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care (2003)Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers (2010)Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force (2013)Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis (2021)Beliefs about generic drugs among elderly adults in hospital-based primary care practices (2008)Patients’ attitudes towards generic drug substitution in Japan (2010)The Effect of an Apparent Change to a Branded or Generic Medication on Drug Effectiveness and Side Effects (2012)
this work references cited by second hop

References

  • 2008Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease432 cited
  • 2005What do primary care patients think about generic drugs?166 cited

Cited by

  • 2011Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications113 cited
  • 2015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review92 cited
  • 2013Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries86 cited
  • 2011European Society for Organ Transplantation Advisory Committee Recommendations on Generic Substitution of Immunosuppressive Drugs81 cited
  • 2015The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians79 cited
  • 2015Potential Clinical and Economic Impact of Switching Branded Medications to Generics76 cited
  • 2014Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark74 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work